Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction

被引:146
作者
Saifuddin, M
Hedayati, T
Atkinson, JP
Holguin, MH
Parker, CJ
Spear, GT
机构
[1] WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110
[2] UNIV UTAH,SCH MED,DIV HEMATOL ONCOL,SALT LAKE CITY,UT 84148
[3] VET AFFAIRS MED CTR,SALT LAKE CITY,UT 84148
关键词
D O I
10.1099/0022-1317-78-8-1907
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human immunodeficiency virus type 1 (HIV-1) can be either resistant or sensitive to complement-mediated destruction depending on the host cells, Incorporation of different levels of host cell CD46, CD55 and CD59 may account for this differential sensitivity to complement. However, it has not been determined whether CD46, CD55 and CD59 can all be incorporated at levels which protect virions. To determine whether each of these proteins can protect HIV-1, virions were derived from CHO cells expressing either human CD46, CD55 or CD59. Virions were shown to incorporate both glycosyl phosphatidylinositol (GPI)-anchored CD55 and CD59 as well as transmembrane CD46. Importantly, all three virus preparations were significantly more resistant to complement lysis than control virus. This study demonstrates that HIV-1 incorporates both transmembrane and GPI-anchored complement control proteins from host cells and that both types of protein increase complement resistance of virus.
引用
收藏
页码:1907 / 1911
页数:5
相关论文
共 21 条
[1]   PRODUCTION OF ACQUIRED IMMUNODEFICIENCY SYNDROME-ASSOCIATED RETROVIRUS IN HUMAN AND NONHUMAN CELLS TRANSFECTED WITH AN INFECTIOUS MOLECULAR CLONE [J].
ADACHI, A ;
GENDELMAN, HE ;
KOENIG, S ;
FOLKS, T ;
WILLEY, R ;
RABSON, A ;
MARTIN, MA .
JOURNAL OF VIROLOGY, 1986, 59 (02) :284-291
[2]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[3]   SPECIFIC INCORPORATION OF CYCLOPHILIN-A INTO HIV-1 VIRIONS [J].
FRANKE, EK ;
YUAN, HEH ;
LUBAN, J .
NATURE, 1994, 372 (6504) :359-362
[4]   THE MECHANISM OF ACTION OF DECAY-ACCELERATING FACTOR (DAF) DAF INHIBITS THE ASSEMBLY OF C-3 CONVERTASES BY DISSOCIATING C2A AND BB [J].
FUJITA, T ;
INOUE, T ;
OGAWA, K ;
IIDA, K ;
TAMURA, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1221-1228
[5]   ANTIBODY TO ADHESION MOLECULE LFA-1 ENHANCES PLASMA NEUTRALIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
GOMEZ, MB ;
HILDRETH, JEK .
JOURNAL OF VIROLOGY, 1995, 69 (08) :4628-4632
[6]  
KOJIMA A, 1993, J IMMUNOL, V151, P1519
[7]  
LISZEWSKI MK, 1992, CURR TOP MICROBIOL, V4, P8
[8]   PHOSPHOLIPID-ANCHORED AND TRANSMEMBRANE VERSIONS OF EITHER DECAY-ACCELERATING FACTOR OR MEMBRANE COFACTOR PROTEIN SHOW EQUAL EFFICIENCY IN PROTECTION FROM COMPLEMENT-MEDIATED CELL-DAMAGE [J].
LUBLIN, DM ;
COYNE, KE .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :35-44
[9]   MOLECULAR-CLONING AND CHROMOSOMAL LOCALIZATION OF HUMAN MEMBRANE COFACTOR PROTEIN (MCP) - EVIDENCE FOR INCLUSION IN THE MULTIGENE FAMILY OF COMPLEMENT-REGULATORY PROTEINS [J].
LUBLIN, DM ;
LISZEWSKI, MK ;
POST, TW ;
ARCE, MA ;
LEBEAU, MM ;
REBENTISCH, MB ;
LEMONS, RS ;
SEYA, T ;
ATKINSON, JP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 168 (01) :181-194
[10]   DECAY-ACCELERATING FACTOR (CD55) PROTECTS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 FROM INACTIVATION BY HUMAN-COMPLEMENT [J].
MARSCHANG, P ;
SODROSKI, J ;
WURZNER, R ;
DIERICH, MP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (01) :285-290